Editorial: STOP or YIELD sign at the intersection of TAVR and amyloidosis?
Authors:
- 25 August 2023
- journal article
- editorial
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 58, 43-44
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Echocardiographic predictors of presence of cardiac amyloidosis in aortic stenosisEuropean Heart Journal - Cardiovascular Imaging, 2022
- Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac AmyloidosisCirculation: Cardiovascular Imaging, 2022
- Transcatheter Aortic Valve Replacement in Aortic Stenosis and Cardiac Amyloidosis: A Systematic Review and Meta-AnalysisESC Heart Failure, 2022
- Cardiac Amyloidosis TreatmentMethodist DeBakey Cardiovascular Journal, 2022
- Prognostic Significance of Cardiac Amyloidosis in Patients With Aortic StenosisJACC: Cardiovascular Imaging, 2021
- Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyNew England Journal of Medicine, 2018
- Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacementEuropean Heart Journal, 2017
- Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosisJournal of Cardiovascular Magnetic Resonance, 2016
- Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic StenosisCirculation: Cardiovascular Imaging, 2016